Clear-cell cancer of the ovary - Is it chemosensitive?

International Journal of Gynecological Cancer

Volumn 15, Issue 3, 2005, Pages 432-437

  Pather, Selvan ^a,b   Quinn, M A ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Carboplatin; Clear cell ovary adenocarcinoma; Paclitaxel

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; GEMCITABINE; PACLITAXEL; PLATINUM; TOPOTECAN;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOSENSITIVITY; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG RESPONSE; DRUG SENSITIVITY; ENDOMETRIOSIS; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; OMENTUM; OVARIECTOMY; OVARY CANCER; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PERITONEUM LAVAGE; PRIORITY JOURNAL; REVIEW; SALPINGOOOPHORECTOMY; TREATMENT FAILURE; TUMOR VOLUME;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DRUG RESISTANCE, NEOPLASM; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 18944379329     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.15305.x     Document Type: Review

References (26)

1. Scully RE, Barlow JF. "Mesonephroma" of ovary. Tumor of Mullerian nature related to the endometrioid carcinoma. Cancer 1967;20:1405-17.
2. Schiller W. Mesonephroma Ovarii. Am J Cancer 1939;35:1-35.
3. Goff BA, Sainz de la Cuesta R, Muntz HG et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 1996;60:412-7.
4. Sugiyama T, Kamura T, Kigawa J et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000;88:2584-9.
5. Czernobilsky B, Silverman BB, Enterline HT. Clear-cell carcinoma of the ovary. A clinicopathologic analysis of pure and mixed forms and comparison with endometrioid carcinoma. Cancer 1970;25:762-72.
6. Tammela J, Geisler JP, Eskew PN Jr, Geisler HE. Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma. Eur J Gynaecol Oncol 1998;19:438-40.
7. Itamochi H, Kigawa J, Sugiyama T, Kikuchi Y, Suzuki M, Terakawa N. Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol 2002;100:281-7.
8. McGuire WP, Hoskins WJ, Brady MF et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
9. Enomoto T, Kuragaki M, Yamazaki N et al. Is clear cell carcinoma and mucinous carcinoma of the ovary sensitive to combination chemotherapy with paclitaxel and carboplatin? Proc Am Soc Clin Oncol 2003;22:447 (abstr 1797).
10. Behbakht K, Randall TC, Benjamin I, Morgan MA, King S, Rubin SC. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 1998;70:255-8.
11. Vergote I, Rustin GJ, Eisenhauer EA et al. Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup. J Natl Cancer Inst 2000;92:1534-5.
12. Rustin GJ, Nelstrop AE, McClean P et al. Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol 1996;14:1545-51.
13. O'Brien ME, Schofield JB, Tan S, Fryatt I, Fisher C, Wiltshaw E. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 1993;49:250-4.
14. Jenison EL, Montag AG, Griffiths CT et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol 1989;32:65-71.
15. Kennedy AW, Biscotti CV, Hart WR, Webster KD. Ovarian clear cell adenocarcinoma. Gynecol Oncol 1989;32:342-9.
16. Trimbos JB, Vergote I, Bolis G et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003;95:113-25.
17. Trimbos JB, Parmar M, Vergote I et al. International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-12.
18. Young RC. Early-stage ovarian cancer: to treat or not to treat. J Natl Cancer Inst 2003;95:94-5.
19. Colombo N, Guthrie D, Chiari S et al. International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003;95:125-32.
20. Recio FO, Piver MS, Hempling RE, Driscoll DL. Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer 1996;78:2157-63.
21. Kita T, Kikuchi Y, Kudoh K et al. Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary. Oncol Rep 2000;7:327-31.
22. Gorai I, Nakazawa T, Miyagi E, Hirahara F, Nagashima Y, Minaguchi H. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. Gynecol Oncol 1995;57:33-46
23. Itamochi H, Kigawa J, Akeshima R et al. Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary. Oncology 2002;62:349-53.
24. Okuda T, Otsuka J, Sekizawa A et al. p53 mutations and over-expression affect prognosis of ovarian endometrioid cancer but not clear cell cancer. Gynecol Oncol 2003;88:318-25.
25. Ho ES, Lai CR, Hsieh YT et al. p53 mutation is infrequent in clear cell carcinoma of the ovary. Gynecol Oncol 2001;80:189-93.
26. Rogers LW, Julian CG, Woodruff JD. Mesonephroid carcinoma of the ovary: a study of 95 cases from the Emil Novak Ovarian Tumor Registry. Gynecol Oncol 1972;1:76-89.